Evidence map›Paper›PMID 35456071›Full record

ArticlePathogens (Basel, Switzerland)2022

The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Survey.

Stephen Raimon Jada, Alfred Dusabimana, Gasim Abd-Elfarag, Samuel Okaro, Nele Brusselaers, Jane Y Carter, Makoy Yibi Logora, Jacopo Mattia Rovarini, Charles R Newton, Robert Colebunders

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 7 countries.

Stephen Raimon JadaAmref Health Africa, Juba P.O. Box 410, South Sudan.
Alfred DusabimanaGlobal Health Institute, University of Antwerp, 2016 Antwerp, Belgium.ORCID 0000-0003-2660-880X
Gasim Abd-ElfaragAmsterdam Center for Global Health, Department of Paediatrics and Department of Global Health, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.
Samuel OkaroAmref Health Africa, Juba P.O. Box 410, South Sudan.
Nele BrusselaersGlobal Health Institute, University of Antwerp, 2016 Antwerp, Belgium.
Jane Y CarterAmref Health Africa Headquarters, Nairobi P.O. Box 30125, Kenya.ORCID 0000-0003-4671-3519
Makoy Yibi LogoraNeglected Tropical Diseases Unit, Ministry of Health, Juba P.O. Box 410, South Sudan.
Jacopo Mattia RovariniAmref Health Africa, Juba P.O. Box 410, South Sudan.
Charles R NewtonDepartment of Psychiatry, University of Oxford, Oxford OX1 2JD, UK.
Robert ColebundersGlobal Health Institute, University of Antwerp, 2016 Antwerp, Belgium.ORCID 0000-0002-1919-1340
University of Antwerp · BEAmref Health Africa · KEAmsterdam Institute for Global Health and Development · NLUniversity of Juba · SSUniversity of Oxford · GB

Funding

European Research Council 671055Research for Health in Humanitarian Crisis (R2HC) ELRHA no grant number
6 · The paper itself

Abstract

A two-phase survey of epilepsy was conducted in selected villages in Mundri West and East Counties (26 June-8 July, 2021), an onchocerciasis-endemic area in Western Equatoria State in South Sudan. In the first phase, households were visited by a trained research team to identify persons suspected to have epilepsy. In the second phase, persons suspected to have epilepsy were interviewed and examined by a clinician to confirm the diagnosis. A total of 364 households agreed to participate in the survey, amounting to 2588 individuals. The epilepsy screening questionnaire identified 91 (3.5%) persons with suspected epilepsy, of whom the diagnosis of epilepsy was confirmed by a clinician in 86 (94.5%). The overall prevalence of confirmed epilepsy was 3.3% (95% CI: 2.7-4.1%), and of nodding syndrome was 0.9% (95% CI: 0.6-1.4%). In 61 (16.8%) households there was at least one person with epilepsy. Only 1212 (46.9%) of 2583 people took ivermectin during the last distribution round in 2021. The annual epilepsy incidence was 77.3/100,000 (95% CI: 9.4-278.9/100,000) and the annual epilepsy mortality was 251.2/100,000 (95% CI: 133.8-428.7/100,000). In conclusion, a high prevalence and incidence of epilepsy was observed in villages in Mundri. Urgent action is needed to prevent children from developing onchocerciasis-associated epilepsy by strengthening the local onchocerciasis-elimination programme.

Indexed as

epilepsyivermectinnodding syndromeOnchocerca volvulusonchocerciasis

Identifiers

PMID35456071
PMCPMC9025150
OpenAlexW4221018650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.